Intera Fund II exits Rototec Group, Europe’s largest provider of geoenergy solutions and an innovative pioneer in the geoenergy field, to a Swedish investment company Formica Capital. Read more
The partnership will provide UVC with resources to accelerate growth, offer best-in-class career opportunities for veterinary practitioners and further broaden its leading offerings for pets and the people who care for themRead more
First quarter 2021 Net profit for the first quarter amounted to MSEK 44.6 (-4.0). Earnings per share amounted to SEK 4.00 (-0.35). Net asset value amounted to MSEK 703 (SEK 63.04 per share) at March 31, 2021, compared to MSEK 679 (SEK 60.87 per share) at March 31, 2020. Net cash amounted to MSEK 180 […]
Read more
The bond matures in December 2023 and has a coupon of 10% p.a. Jacktel AS is a wholly-owned subsidiary of Macro Offshore Ltd, an offshore accommodation provider with an established track record in providing safe, efficient and reliable accommodation services. Macro Offshore is a portfolio company of Nordic Capital CV1 LP, where NAXS is an […]
Read more
– Itiviti has grown significantly during Nordic Capital’s ownership, creating a global force in capital markets technology and infrastructure
– By joining forces with global Fintech leader Broadridge (NYSE: BR), Itiviti is taking the next step in enhancing its capital markets capabilities and extending its global reach
Read more
Handicare offers solutions to increase the independence of disabled or elderly people, and to facilitate for their care providers and family. The offering encompasses a comprehensive range of curved and straight stairlifts, transfer, lifting and repositioning aids and vehicle adaptations. Handicare is a global company with sales in some 40 countries and is one of […]
Read more
Nordic Capital, a leading global healthcare private equity investor, invests in LEO Pharma and becomes an active minority owner and partner to the LEO Foundation. The investment will support LEO Pharma on its journey to strengthening its global leadership in medical dermatology and help accelerate innovation and growth. The LEO Foundation will remain the company’s majority owner.
Read more